Method for decreasing inflammation and stress in a mammal
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-036/00
A61K-036/54
A61K-031/70
출원번호
US-0012317
(2008-02-01)
등록번호
US-9415083
(2016-08-16)
발명자
/ 주소
Massimino, Stefan Patrick
Davenport, Gary Mitchell
Hayek, Michael Griffin
Roth, George
Ingram, Donald K.
출원인 / 주소
MARS, INCORPORATED
대리인 / 주소
Mars, Incorporated
인용정보
피인용 횟수 :
0인용 특허 :
210
초록▼
A method for decreasing inflammation and stress in a mammal comprising; administration to a mammal a composition comprising a glucose anti-metabolite; and wherein said composition comprises amounts of the glucose anti-metabolite sufficient to lower a level of a C-reactive protein in the blood of the
A method for decreasing inflammation and stress in a mammal comprising; administration to a mammal a composition comprising a glucose anti-metabolite; and wherein said composition comprises amounts of the glucose anti-metabolite sufficient to lower a level of a C-reactive protein in the blood of the mammal subsequent to administration of the glucose anti-metabolite.
대표청구항▼
1. A method for decreasing inflammation and stress in a mammal comprising: administration to a mammal a composition comprising avocado fruit; and wherein said composition comprises amounts of the avocado fruit sufficient to lower a level of a C-reactive protein in the blood of the mammal subsequent
1. A method for decreasing inflammation and stress in a mammal comprising: administration to a mammal a composition comprising avocado fruit; and wherein said composition comprises amounts of the avocado fruit sufficient to lower a level of a C-reactive protein in the blood of the mammal subsequent to administration of the avocado; wherein administration is daily and the dose of avocado fruit is about 100 mg/kg to about 200 g/kg; and wherein the composition comprises less than 5% of said avocado fruit, by weight of the composition. 2. The method of claim 1, wherein the level of said C-reactive protein in the blood subsequent to administration of the avocado is from about 0 mg/L to about 100 mg/L. 3. The method of claim 1, wherein the administration is oral. 4. The method of claim 1, wherein said composition is selected from the group consisting of pet food, dog food, cat food, treats, chew, biscuits, gravy, sauce, beverage, supplemental water, and combinations thereof. 5. The method of claim 4, wherein the composition is a nutritionally balanced pet food composition. 6. The method of claim 1, further comprising animal protein, plant protein, farinaceous matter, vegetables, fruit, egg-based materials, undenatured proteins, food grade polymeric adhesives, gels, polyols, starches, gums, flavorants, seasonings, salts, colorants, time-release compounds, minerals, vitamins, antioxidants, prebiotics, probiotics, aroma modifiers, lipids, and combinations thereof. 7. The method of claim 1, wherein the level of said C-reactive protein in the blood subsequent to administration of the avocado is from about 0 mg/L to about 100 mg/L. 8. A method for decreasing inflammation and stress in a mammal comprising: administration to a mammal a composition comprising mannoheptulose; and wherein said composition comprises amounts of the mannoheptulose sufficient to lower the level of a C-reactive protein in the blood of the mammal subsequent to administration of the mannoheptulose; wherein administration is daily and the dose of mannoheptulose is about 2 mg/kg to about 5 mg/kg; and wherein the composition comprises less than 5% of said mannoheptulose, by weight of the composition. 9. The method of claim 8, wherein the level of said C-reactive protein in the blood subsequent to administration of the mannoheptulose is from about 0 mg/L to about 100 mg/L. 10. The method of claim 8, wherein the level of said C-reactive protein in the blood subsequent to administration of the mannoheptulose is from about 0.1 mg/L to about 60 mg/L. 11. The method of claim 8, wherein the level of said C-reactive protein in the blood subsequent to administration of the mannoheptulose is from about 0.2 mg/L to about 40 mg/L. 12. The method of claim 8, wherein said mannoheptulose is selected from the group consisting of avocado extract, avocado, and combinations thereof. 13. The method of claim 8, wherein the administration is oral. 14. The method of claim 8, wherein said composition is selected from the group consisting of pet food, dog food, cat food, treats, chew, biscuits, gravy, sauce, beverage, supplemental water, and combinations thereof. 15. The method of claim 8, wherein the composition is a nutritionally balanced pet food composition. 16. The method of claim 8, further comprising animal protein, plant protein, farinaceous matter, vegetables, fruit, egg-based materials, undenatured proteins, food grade polymeric adhesives, gels, polyols, starches, gums, flavorants, seasonings, salts, colorants, time-release compounds, minerals, vitamins, antioxidants, prebiotics, probiotics, aroma modifiers, lipids, and combinations thereof. 17. A method for decreasing inflammation and stress in a mammal comprising: administration to a mammal a composition comprising avocado extract; and wherein said composition comprises amounts of the avocado extract sufficient to lower the level of a C-reactive protein in the blood of the mammal subsequent to administration of the avocado extract; wherein administration is daily and the avocado extract comprises a dose of glucose anti-metabolite at about 2 mg/kg to about 5 mg/kg; and wherein the composition comprises less than 5% of said avocado extract, by weight of the composition. 18. The method of claim 17, wherein the level of said C-reactive protein in the blood subsequent to administration of the avocado extract is from about 0 mg/L to about 100 mg/L. 19. The method of claim 17, wherein the level of said C-reactive protein in the blood subsequent to administration of the avocado extract is from about 0.1 mg/L to about 60 mg/L. 20. The method of claim 17, wherein the level of said C-reactive protein in the blood subsequent to administration of the avocado extract is from about 0.2 mg/L to about 40 mg/L. 21. The method of claim 17, wherein the administration is oral. 22. The method of claim 17, wherein said composition is selected from the group consisting of pet food, dog food, cat food, treats, chew, biscuits, gravy, sauce, beverage, supplemental water, and combinations thereof. 23. The method of claim 17, wherein the composition is a nutritionally balanced pet food composition. 24. The method of claim 17 further comprising animal protein, plant protein, farinaceous matter, vegetables, fruit, egg-based materials, undenatured proteins, food grade polymeric adhesives, gels, polyols, starches, gums, flavorants, seasonings, salts, colorants, time-release compounds, minerals, vitamins, antioxidants, prebiotics, probiotics, aroma modifiers, lipids, and combinations thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (210)
Bengs,Holger; Brunner,Anette, α-Amylase-resistant starch for producing foodstuff and medicaments.
Leer, Robert Jan; Pouwels, Pieter Hendrik; Conway, Patricia Lynne, ADHERENCE FACTORS OF NON PATHOGENIC MICROORGANISMS AND APPLICATIONS THEREOF FOR SCREENING MICROORGANISMS FOR SPECIFIC PROBIOTIC PROPERTIES; NOVEL PHARMACEUTICAL COMPOSITIONS AND FOOD ADDITIVES COMPRI.
Leonard Walter G. (1017 Main St. Melrose MA 02176) Doble ; Jr. Henry P. (Sunnyview Dr. Redding CT 06875) Nuckols Walter S. (119 Putnam Park Rd. Bethel CT 06801), Calendar-oriented pill dispenser.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Collins, John Kevin; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Canine probiotic .
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Collins, John Kevin; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Canine probiotic Bifidobacterium .
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Collins, John Kevin; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Canine probiotic Lactobacilli.
Henderson, Todd R.; Lippiello, Louis; Filburn, Charles; Griffin, David, Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals.
Rochat, Florence; Schiffrin, Eduardo; Guigoz, Yves, Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters.
Marttila Esko (Perttula FIX) Larma Ilkka (Espoo FIX) Vahervuo Kari (Espoo FIX) Uotila Jaakko (Espoo FIX), Composition for the oral administration of pharmaceuticals.
Sinclair, David A.; Howitz, Konrad T.; Zipkin, Robert E.; Bitterman, Kevin J.; Lamming, Dudley W., Compositions for manipulating the lifespan and stress response of cells and organisms.
Gren, Torkel; Ringberg, Anders; Wikberg, Martin; Wald, Randy J., Controlled release bead, a method of producing the same and multiple unit formulation comprising it.
Lamothe Jean-Pierre H. G. (Toulouse FRX) Marchenay Yves G. (Boulogne FRX) Monsan Pierre F. (Blagnac FRX) Paul Francois M. B. (Toulouse FRX) Pelenc Vincent (Toulouse FRX), Cosmetic compositions containing oligosaccharides.
Reddy Malireddy S. (6983 S. Telluride St. Aurora CO 80016), Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products.
Collings George F. (Auburn KS) Stout Neil P. (Topeka KS) Cowell Christopher S. (Topeka KS) Plas Stephen J. (Topeka KS), Extruded dog treat food product having improved resistance to breakage.
Anantharaman Helen Gillian ; Ballevre Olivier,CHX ; Rochat Florence,CHX, Gelatinized cereal product containing oligosaccharide and processes of preparing and using same.
Reid Gregor (London CAX) Bruce Andrew W. (Toronto CAX), Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections.
Vidal, Karine; Donnet-Hughes, Anne; Granato, Dominique-Anne; Corthesy-Theulaz, Irene, Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria.
Piccirilli, Antoine; Piccardi, Nathalie; Msika, Philippe; Paul, François; Bredif, Stéphanie, Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency.
Piccirilli, Antoine; Piccardi, Nathalie; Msika, Philippe; Paul, François; Bredif, Stéphanie, Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin.
Nahill Edmond P. (56 Pleasant St. Methuen MA 01844) Nahill James C. (9 Sunset Ave. Methuen MA 01844) Nahill William A. (10 Glen Ave. Methuen MA 01844) Nahill Arthur (51 East St. Methuen MA 01844), Medicine dispensing system.
Pitha, Josef; Roth, George S; Hayek, Michael Griffin; Massimino, Stefan Patrick; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Burr, John Russell, Method of maintaining and/or attenuating a decline in quality of life.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Collins, John Kevin; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Method of treating diarrhea in a canine.
Chen, Hao; Liu, Ming; Sathyamoorthy, Malathi; Su, Qi; Leary, Lisa; Zhong, Wayne Shaobin, Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Collins, John Kevin; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Methods of treatment or prevention of gastrointestinal disorders using canine probiotic bifidobacterium.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Methods of use of probiotic Lactobacilli for companion animals.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Methods of use of probiotic bifidobacteria for companion animals.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Methods of use of probiotic for companion animals.
Sozzi Tomaso (Lausanne CHX) Schrenk Alfred (Orbe CHX) Buhler Marcel (Tolochenaz CHX), Microcapsule containing a microorganism and a process for its production.
Stern Norman J. (Athens GA) Bailey J. Stan (Athens GA) Cox ; Jr. Nelson A. (Athens GA) Blankenship Leroy C. (Athens GA), Nucosal competitive exclusion flora.
Garcia-Rodenas, Clara Lucia; Bergonzelli, Gabriela; Rochat, Florence; Turini, Marco Enrico; Corthesy-Theulaz, Irène; Cherbut, Christine, Nutritional formula for optimal gut barrier function.
Cavaliere Ved. Vesely Renata Maria Anna,ITX ; De Simone Claudio,ITX, Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections and related method.
Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
Grahn Eva E. (Bondegatan 32 UmeS-902 54 SEX) Holm Stig E. F. (Gimonsvgen 25 UmeS-902 40 SEX), Pharmaceutical preparation for controlling pathogenic intestinal bacteria.
Hatano Harumi,JPX ; Ito Takahiro,JPX ; Ishibashi Takashi,JPX ; Yoshino Hiroyuki,JPX ; Mizobe Masakazu,JPX, Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract.
Ikushima Heiji (Saitama-ken JPX), Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the int.
Plail, Regina; Schatzmayr, Gerd; Binder, Eva Maria; Mohnl, Michaela; Klimitsch, Alfred; Nitsch, Sabine; Klose, Viviana, Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof.
Zink,Ralf; Reniero,Roberto; Rochat,Florence; Cavadini,Christoph; Der Weid,Thierry; Schiffrin,Eduardo; Benyacoub,Jalil; Rousseau,Virginie; Perez,Pablo, Probiotics for pet food applications.
Zink,Ralf; Reniero,Roberto; Rochat,Florence; Cavadini,Christoph; Von Der Weid,Thierry; Schiffrin,Eduardo; Benyacoub,Jalil; Rousseau,Virginie; Perez,Pablo; Knorr,Ruth, Probioticstrains for pets.
Ors Patrick (Epernay FRX) Hennequin Dominique (Epernay FRX) Meybeck Alain (Courbevoie FRX), Process and apparatus for forming solid particles by cross-linking drops of a cross-linkable material with a free-fallin.
Rutherford William M. (Des Moines IA) Allen Jack E. (Boonville IA) Schlameus Herman W. (San Antonio TX) Mangold Donald J. (San Antonio TX) Harlowe ; Jr. William W. (San Antonio TX) Lebeda Joseph R. (, Process for preparing rotary disc fatty acid microspheres of microorganisms.
Reimann Josef (Kirchlintein-Hohenaverbergen DEX) Sirel Tas (Verden-Walle DEX) Steinberg Eckhart (Verden DEX) Hornig Rolf (Kirchlintein-Luttum DEX) Czempik Klaus (Minden DEX) Khler Friedrich (Martfeld, Process for the production of a lumpy meat emulsion product.
Miller James G. (Ellicott City MD) Wax Michael J. (Bethesda MD) Wormsbecher Richard F. (Highland MD) Aller Leo B. (Severna Park MD) Durham Donald R. (Gaithersburg MD) Chmurny Alan B. (Frederick MD), Process upset-resistant inorganic supports for bioremediation.
Shenouda Soliman (Tarrytown NY) Clausi Adolph (Cos Cob CT) Rogers Ann M. (Rivervale NJ) El-Hag Nabil (Putnam Valley NY), Reduction of microbial population on surface of food materials.
Reddy Malireddy S. (6983 S. Telluride St. Aurora CO 80016), Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconos.
DeNeale Richard J. (Morrisonville NY) Guley Paul C. (Plattsburgh NY) Milosovich George (Rouses Point NY), Sustained release pharmaceutical compositions.
Friedman Mark I. (Merion PA) Tordoff Michael G. (Philadelphia PA) DiNovi Michael J. (Philadelphia PA) Rafka Robert J. (Ardmore PA), Use of 2,5-anhydro-D-mannitol as a food intake modifier.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.